This Canadian pharmaceutical company has made headlines again—this time for both its scientific strides with a cannabis inhaler and boardroom conflicts. A proxy battle is brewing with a dissident shareholder, raising concerns about governance and financial stability.
Source: MediPharm Labs.
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | Canopy Growth trims losses, eyes profit in 2026
2 | Diversify away from cannabis retail with this technology stock
3 | Charlotte’s Web unravels new approach to hemp-derived THC
Top Cannabis Stocks May 23 to May 29, 2025
1. T.TLRY | 4,701 views | Tilray Brands Inc.
2. T.LABS | 4,276 views | Medipharm Labs Corp.
3.C.CURA | 3,421 views | Curaleaf Holdings Inc.
4. T.WEED | 2,504 views | Canopy Growth Corp.
5. T.OGI | 396 views | Organigram Holdings Inc.
6. T.ACB | 392 views | Aurora Cannabis Inc.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.